Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:47 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | Nextech Crossover I GP S.a r.l. | 5,285,714 7.500% | 1,000,000 (+23.33%) | View |
| 2024-11-14 5:45 pm Purchase | 13G | Mersana Therapeutics Inc. MRSN | Nextech Crossover I GP S.a r.l. | 12,067,246 9.800% | 5,818,403 (+93.11%) | View |
| 2024-05-24 4:15 pm Purchase | 13G | CONTEXT THERAPEUTICS INC CNTX | Nextech Crossover I GP S.a r.l. | 7,419,355 9.900% | 7,419,355 (New Position) | View |
| 2024-05-17 08:26 am Purchase | 13G | Mersana Therapeutics Inc. MRSN | Nextech Crossover I GP S.a r.l. | 6,248,843 5.100% | 6,248,843 (New Position) | View |
| 2023-11-02 4:15 pm Purchase | 13G | Ambrx Biopharma Inc. AMAM | Nextech Crossover I GP S.a r.l. | 3,129,300 5.000% | 3,129,300 (New Position) | View |
| 2023-08-21 4:16 pm Purchase | 13G | Tango Therapeutics Inc. TNGX | Nextech Crossover I GP S.a r.l. | 5,533,980 5.400% | 5,533,980 (New Position) | View |
| 2023-07-07 4:15 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | Nextech Crossover I GP S.a r.l. | 4,285,714 7.900% | 4,285,714 (New Position) | View |